Dexamethasone 4 mg/ml solution for injection is recommended for systemic administration by intravenous or intramuscular injection when oral therapy is not feasible or desirable in the following conditions. Endocrine disorders Primary or secondary adrenocortical insufficiency (Hydrocortisone or cortisone is the first choice, but synthetic analogues may be used with mineralocorticoids where applicable and, in infancy, mineralocorticoid supplementation is particularly important) Non-endocrine disorders Dexamethasone 4 mg/ml solution for injection may be used in the treatment of non-endocrine corticosteroid-responsive conditions, including: Allergy and anaphylaxis Angioneurotic oedema and anaphylaxis Gastrointestinal Crohn's disease and ulcerative colitis Infection (with appropriate chemotherapy) Miliary tuberculosis and endotoxic shock Neurological disorders Raised intracranial pressure secondary to cerebral tumours and infantile spasms Respiratory Bronchial asthma and aspiration pneumonitis Skin disorders Toxic epidermal necrolysis Shock Adjunctive treatment where high pharmacological doses are needed. Treatment is an adjunct to and not a substitute for, specific and supportive measures the patient may require. Dexamethasone has been shown to be beneficial when used in the early treatment of shock, but it may not influence overall survival. Subcutaneous administration In palliative care, patients receiving corticosteroids for symptoms such as fatigue, anorexia, refractory nausea and vomiting or adjuvant analgesia and symptomatic treatment of cord compression or raised intracranial pressure, dexamethasone 4 mg/ml solution for injection may be administered subcutaneously (see section 4.2) as an alternative to the oral route when the latter is unacceptable or no longer feasible. Local administration Dexamethasone 4 mg/ml solution for injection is suitable for intraarticular or soft-tissue injection as adjunctive therapy for short-term administration in: Soft-tissue disorders Such as carpal tunnel syndrome and tenosynovitis Intraarticular disorders Such as rheumatoid arthritis and osteoarthritis with an inflammatory component Dexamethasone 4 mg/ml solution for injection may be injected intralesionally in selected skin disorders such as cystic acne vulgaris, localised lichen simplex, and keloids.Looking for ideal Dexamethasone Phosphate Injection Manufacturer & supplier ? We have a wide selection at great prices to help you get creative. All the Injection Dexamethasone Sodium Phosphate 1mg are quality guaranteed. We are China Origin Factory of Dexamethasone Sodium Phosphate Injection Use. If you have any question, please feel free to contact us.